uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
24.11
-0.60 (-2.43%)
At close: Feb 11, 2026, 4:00 PM EST
24.11
0.00 (0.00%)
Pre-market: Feb 12, 2026, 8:31 AM EST
uniQure Market Cap
uniQure has a market cap or net worth of $1.5 billion as of February 12, 2026. Its market cap has increased by 95.02% in one year.
Market Cap
1.50B
Enterprise Value
1.34B
1-Year Change
95.02%
Ranking
Category
Stock Price
$24.11
Market Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $1.50B, an increase of 832.25%. That is a compound annual growth rate of 28.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 1.54B | 3.26% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Agios Pharmaceuticals | 1.62B |
| Tyra Biosciences | 1.60B |
| Relay Therapeutics | 1.59B |
| Biohaven | 1.56B |
| Oruka Therapeutics | 1.56B |
| AnaptysBio | 1.53B |
| Monte Rosa Therapeutics | 1.50B |
| Novavax | 1.46B |